Baseline low modified health assessment questionnaire (MHAQ) predicts the state of remission estimated by clinical disease activity index and MHAQ at 1 year in tocilizumab-treated rheumatoid arthritis patients

Clin Exp Rheumatol. 2014 May-Jun;32(3):445. Epub 2014 May 12.

Authors

S Kawashiri¹, Y Ueki, K Migita, H Nakamura, K Aoyagi, A Kawakami

Affiliation

¹ Department of Public Health, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. shin-ya@hotmail.co.jp.

PMID: 24850342

No abstract available

Publication types

Letter

MeSH terms

Aged
Antibodies, Monoclonal, Humanized / therapeutic use*
Antirheumatic Agents / therapeutic use
Arthritis, Rheumatoid / drug therapy*
Health Status*
Humans
Logistic Models
Middle Aged
Predictive Value of Tests
Remission Induction
Surveys and Questionnaires*

Substances

Antibodies, Monoclonal, Humanized
Antirheumatic Agents
tocilizumab